Book Description:
The purpose of this book is to introduce the importance of vitamins and its use in the treatment of schizophrenia, mood and movement disorders. This subject has been already known for many years. In the last years this issue has become "hot" again. To date there is new modern data based on controlled studies leading to a new attitude in consumption of these preparations. The present experience is related to higher doses in contrast to those which were used previously in addition to the scientific base data consisting of new knowledge about the mechanism of action and the influence on different dimensions. The chapters will include theoretical and scientific background as well as practical data based conclusions which might be useful for the clinician in everyday practice.

We’ve partnered with Copyright Clearance Center to make it easy for you to request permissions to reuse Nova content.
For more information, click here or click the "Get Permission" button below to link directly to this book on Copyright Clearance Center's website.

Table of Contents:
Introduction: FOOD SUPPLEMENTS – A NEW HOPE FOR SCHIZOPHRENIA AND MOOD DISORDERS
(Vladimir Lerner and Chanoch Miodownik; Faculty of Health Sciences, Ben-Gurion Univ. of the Negev, Be’er-Sheva, Israel), pp. 1-4

1. VITAMIN C IN PSYCHIATRY: PAST, PRESENT AND FUTURE
(Joseph Bergman and Anatoly Kreinin; Mental Health Center Tirat Carmel, Technion, Rappaport Faculty of Medicine, Haifa, Israel), pp. 5-25

2. VITAMIN B6 AS TREATMENT OF PSYCHOTROPIC DRUG-INDUCED MOVEMENT DISORDERS AND ADD-ON TREATMENT OF SCHIZOPHRENIA
(Vladimir Lerner and Chanoch Miodownik, Division of Psychiatry, Ministry of Health Be'er Sheva Mental Health Center, Faculty of Health Sciences Ben-Gurion University of the Negev, Be're-Sheva, Israel), pp. 27-56

3. VITAMIN B6 IN TREATING MOOD AND RELATED DISORDERS
(Chanoch Miodownik and Vladimir Lerner, Division of Psychiatry, Ministry of Health Be'er Sheva Mental Health Center, Faculty of Health Sciences Ben-Gurion University of the Negev, Be're-Sheva, Israel), pp. 57-66

4. VITAMIN B12 AND FOLIC ACID IN COGNITIVE AND MENTAL DISORDERS
(Yacov Grinshpun; Soroka Medical Center, Be'er Sheva, Israel; Memory Clinic, Mental Health Center, Be'er Sheva, Israel; Memory Clinic, Mental Health Center, Be'er Sheva, Israel; Faculty of Health Sciences, Ben Gurion Univ. of the Negev, Be'er Sheva, Israel and Tzvi Dwolatzky, Mental Health Center Be'er Sheva, Israel; Memory Clinic, Mental Health Center, Be'er Sheva, Israel; Faculty of Health Sciences, Ben Gurion Univ. of the Negev, Be'er Sheva, Israel), pp. 67-79

5. HOMOCYSTEINE AS A RISK FACTOR IN SCHIZOPHRENIA
(Joseph Levine, Anna Bromberg, and Tzvi Dwolatzky; Division of Psychiatry, Be’er Sheva Mental Health Center; Faculty of Health Sciences, Ben-Gurion Univ. of the Negev, Be’er-Sheva, Israel), pp. 81-96

6. OMEGA-3 IN PSYCHIATRY
(Boris Nemets, Chanoch Miodownik and Vladimir Lerner; Division of Psychiatry, Ministry of Health, Be’er Sheva Mental Health Center,
Faculty of Health Sciences, Ben-Gurion Univ. of the Negev, Be’er-Sheva, Israel), pp. 97-118

7. NOVEL NEUROPROTECTIVE AGENTS FOR SCHIZOPHRENIA: NEUROSTEROIDS, MEMANTINE, BEXAROTENE AND L-THEANINE
(Michael S. Ritsner; Psychiatry Dept. Rappaport Faculty of Medicine, Technion, Israel Inst. of Technology, Haifa, Sha'ar Menashe Mental Health Center, Israel), pp. 119-150

8. MELATONIN AND SCHIZOPHRENIA
(Yoram Barak and Dov Aizenberg; Abarbanel Mental Health Center, Geha Mental Health Center, affiliated with the Sackler Faculty of Medicine, Tel-Aviv Univ., Israel), pp. 151-158

Index